CD4 and cancer: In the context of cancer, CD4+ T cell subpopulations, immunosuppressive regulatory (Tregs), and pro-inflammatory T helper 17 (Th17) cells, which normally act to fine-balance the adaptive immune responses, promote cancer progression and metastasis.